Oxaliplatin-based regimens | Irinotecan-based regimens | Regimens including molecular targeted agents | |
---|---|---|---|
(n = 13) | (n = 31) | (n = 11) | |
Base-case | 418,463 | 215,499 | 705,460 |
Hospitalization | 390,487 | 223,597 | 690,343 |
Outpatient | 327,177 | 160,287 | 627,033 |
Imaging Max | 433,991 | 215,499 | 720,541 |
Imaging Min | 418,463 | 199,972 | 705,013 |
Brand drug | 418,463 | 215,888 | 707,715 |
Generic drug | 404,097 | 214,046 | 694,883 |